Atreca, Inc., Licenses Transformational “Immune Repertoire Capture” Technology From Stanford University

Published: Aug 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc., today announced that Stanford University has granted the company an exclusive license to transformational technology for harnessing the power of the immune response to generate a wide range of medical products.

Back to news